News

Laboratorios Rovi (ROVI) will publish its Q2 2025 results on Thursday 24 July at 10 a.m. We expect some improvement on the ...
Sanofi is buying U.K. biotechnology company Vicebio for up to $1.6 billion in a deal that seeks to strengthen the French drugmaker's portfolio of respiratory vaccines and leave pipeline setbacks ...
The deal seeks to strengthen the drugmaker’s portfolio of respiratory vaccines and help it move on from pipeline setbacks.
Andrew Lo asked ChatGPT for its opinion on Moderna Inc., a biotech stock that soared during the pandemic era. The advice: ...
Lebanese-born Armenian-American entrepreneur and philanthropist Noubar Afeyan has joined the likes of the world’s richest man ...
Sanofi has struck a deal to buy Vicebio for $1.15 billion upfront, securing preclin | Sanofi has struck a deal to buy Vicebio ...
Design collective Fahrenheit 180 has created tiles using discarded shells from oyster farms to show the "potential of ...
Tom Romary's bold plan for BizTrip.Ai is to make the travel search bar obsolete, a phenomenon that is gaining ground beyond ...
I received a call from a cousin that his brother had passed away.  The deceased was sixty-four years old, considerably younger than yours ...
There’s still plenty of room for growth as the AI race continues to unfold. Still, some growth investors are already moving ...
The CDC declared the end of its emergency response to H5N1 avian flu as a health threat to humans, David Murray writes.